<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The technique of simultaneous fluorescence immunophenotyping and interphase cytogenetics (FICTION) was applied in four cases of <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic (working formulation: follicular) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim in this study was to establish whether secondary chromosome aberrations known from a prior cytogenetic analysis were detectable in both kappa- and lambda-expressing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells from the same <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patient </plain></SENT>
<SENT sid="2" pm="."><plain>One of the cases did indeed contain kappa- and lambda-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="3" pm="."><plain>On the basis of our results, we reflect on the events that take place during early development of <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>